REMEGEN (09995) has issued an announcement regarding the outcomes of its Annual General Meeting.

At the meeting, Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, and Ms. Fang Yi were elected or re-elected as executive directors for the company's third-term board.

Dr. Wang Liqiang was re-elected as a non-executive director for the third-term board.

Mr. Song Xiliang, Mr. Huang Guobin, and Mr. Chen Yunjin were elected or re-elected as independent non-executive directors for the third-term board.

Following a democratic election at a staff congress held on June 16, 2026, Mr. Wang Yuxiao was elected as a staff representative director (executive director) for the third-term board.

Mr. Wang Yuxiao's term will commence from the date of the Annual General Meeting and last for three years, concluding upon the expiry of the third-term board's tenure.

At the inaugural meeting of the third-term board held on June 16, 2026, several resolutions were passed.

Mr. Wang Weidong was re-elected as the Chairman of the third-term board.

Dr. Fang Jianmin was re-elected as the company's Chief Executive Officer.

The terms for these positions will also commence from the date of the Annual General Meeting and last for three years, concluding upon the expiry of the third-term board's tenure.